<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1105075</article-id><article-id pub-id-type="publisher-id">OALibJ-89411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical and Histopathological Characteristics of Gastric Adenocarcinoma in Yemeni Patients: A 2 Years Prospective Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdulgafoor</surname><given-names>Kassim</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Saeed</surname><given-names>Thabet</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sadik</surname><given-names>Al-Fakih</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohammed</surname><given-names>Alqobaty</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ramea</surname><given-names>Alathwary</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sana</surname><given-names>Ameen</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Hematology, Internal Medicine, Faculty of Medicine, Taiz University, Taiz, Yemen</addr-line></aff><aff id="aff4"><addr-line>Pathology, Pathology Department, Faculty of Medicine, Taiz University, Taiz, Yemen</addr-line></aff><aff id="aff5"><addr-line>Internal Medicine, Internal Medicine Department, Faculty of Medicine, Taiz University, Taiz, Yemen</addr-line></aff><aff id="aff1"><addr-line>Gastroenterology and Hepatology, Internal Medicine, Faculty of Medicine, Taiz University, Taiz, Yemen</addr-line></aff><aff id="aff3"><addr-line>Surgery, Surgical Department, Faculty of Medicine, Taiz University, Taiz, Yemen</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>12</month><year>2018</year></pub-date><volume>05</volume><issue>12</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>27,</day>	<month>November</month>	<year>2018</year></date><date date-type="rev-recd"><day>22,</day>	<month>December</month>	<year>2018</year>	</date><date date-type="accepted"><day>25,</day>	<month>December</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Objectives: To study the clinical and the histopathological characteristics of gastric cancer concentrating more on the gastric adenocarcinoma. Design: Prospective study of one hundred thirty Yemeni patients confirmed with gastric malignancies during the period from July 2016 to July 2018. Setting: Specialized center of gastrointestinal and liver diseases in Ibb city, Yemen. Subjects: All patients with histopathologically proved gastric cancer. Results: We collect 130 patients with gastric cancer during the study period, they were 93 males and 37 females with age ranged between 25 years and 100 years and the mean age was 64.98 &#177; 15.15 years. The most frequent clinical presentations of our patients were epigastric pain (81.5%), weight loss (74.6%), dysphagia (46.9%), vomiting (49.2%), palpable epigastric mass (19.2%) and hematemesis/melena (20%). Proximally located gastric cancer represented 46.1%; 48.9% of males patients and 38.9% of females patients. Adenocarcinoma constituted 92.4%, of which the intestinal type was 82.5% and the diffuse type was 17.5%. Squamous cancer accounted in 1.5%, and the non-epithelial tumor was in 6.1%, of which 4.6% were lymphoma and 1.5% were GIST. Conclusion: Adenocarcinomas are the major histological type of gastric cancer and represent 92.4% of all gastric malignancies in which intestinal type represented 82.5% and diffuse type represented 17.5%, and proximally located gastric cancer within stomach was the commonest in both sexes.
 
</p></abstract><kwd-group><kwd>Gastric Adenocarcinoma</kwd><kwd> Histopathology</kwd><kwd> Lauren Classification</kwd><kwd> Yemen</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Globally, the incidence and mortality of gastric cancer have fallen dramatically over the past 70 years [<xref ref-type="bibr" rid="scirp.89411-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref2">2</xref>]. However, gastric cancer is currently the fourth most common cancer and the second leading cause of cancer-related death worldwide [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref4">4</xref>]. In 2012, the World Health Organization estimated about one million new cases of gastric cancer, more than 70% of the cases (677,000 cases) occurred in developed countries with 2:1 male to female ratio and half of those cases were on the Asian continent mainly China [<xref ref-type="bibr" rid="scirp.89411-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref6">6</xref>]. There are two main histologic variants of gastric adenocarcinoma: “intestinal-type” (which resembles intestinal cancers in forming glandular structures) and “diffuse” (which is poorly differentiated, has signet-ring cells, and lacks glandular formation) according to Lauren’s classification [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref8">8</xref>]. The intestinal type is more common in males, blacks, and older age groups, whereas the diffuse type does not show gender predominance, and is more frequent in younger individuals [<xref ref-type="bibr" rid="scirp.89411-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref10">10</xref>]. Intestinal type tumors predominate in high-risk nations of gastric cancer, such as East Asia, Eastern Europe, Central and South America [<xref ref-type="bibr" rid="scirp.89411-ref9">9</xref>]. Moreover diffuse type adenocarcinomas have a more uniform geographic distribution [<xref ref-type="bibr" rid="scirp.89411-ref11">11</xref>]. The recent decrease in the incidence of gastric cancer worldwide caused by decline in the incidence of the intestinal type tumors [<xref ref-type="bibr" rid="scirp.89411-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref12">12</xref>]. However; the incidence of diffuse type gastric carcinoma, particularly the signet ring type, has been increasing [<xref ref-type="bibr" rid="scirp.89411-ref13">13</xref>]. The two main tumor sites of gastric cancer are proximal (cardia) and distal (non-cardia) and despite a dramatic decline in distal gastric cancers, proximal tumors have been increasing in incidence especially in the Western countries [<xref ref-type="bibr" rid="scirp.89411-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref15">15</xref>]. They may differ in genetic susceptibility, pathologic profile, clinical presentation, and prognosis [<xref ref-type="bibr" rid="scirp.89411-ref16">16</xref>]. The observed differences between gastric cancers by anatomic site suggest that they are distinct diseases with different etiologies [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref18">18</xref>]. Although the etiology of gastric cancer is complex, the most important and well-studied risk factors are Helicobacter pylori (H. pylori) infections, environmental factors, nutritional factors and host genetic factors, such as a positive family history for gastric cancer and/or a genetic pro-inflammatory profile [<xref ref-type="bibr" rid="scirp.89411-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref19">19</xref>]. Several environmental exposures have already been identified as risk factors for gastric cancer including diet, smoking, bacterial infections and a variety of occupational exposures [<xref ref-type="bibr" rid="scirp.89411-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref20">20</xref>]. The effects of H. pylori on gastric tumor development may vary by anatomical site in which there is a strong link between H. pylori infection and distal gastric cancer and not the proximal one [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref21">21</xref>]. Gastric cancer is generally asymptomatic until the disease is quite advanced [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>]. Symptoms of gastric cancer are nonspecific and may include anorexia, weight loss, abdominal pain or discomfort, nausea, vomiting, early satiety and gastrointestinal bleeding [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>]. There are only a few studies regarding the epidemiologic distribution of gastric cancer in developing countries and the Middle East [<xref ref-type="bibr" rid="scirp.89411-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref24">24</xref>]. According to the WHO, the reported incidence of gastric cancer in the neighboring countries such as Saudi Arabia in 2012 was 3.14% [<xref ref-type="bibr" rid="scirp.89411-ref25">25</xref>]. It is not known whether the incidence has changed in the Middle East, and the actual epidemiologic distribution of gastric cancer according to age, sex, location within the stomach, and tumor histologic types are not fully established in this part of the world [<xref ref-type="bibr" rid="scirp.89411-ref26">26</xref>].</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>This study was carried out in Ibb city-Yemen during the period from July 2016 and July 2018 at gastrointestinal and liver diseases center. We enrolled in this study consecutive patients with histologically confirmed gastric cancer. Patients with endoscopic gastric tumor without histological confirmation were excluded. To all patients included in the study sociodemographic data, presenting symptoms, clinical findings, risk factors, ultrasonographic, endoscopic and histopathologic findings were collected. Verbal consent was also obtained from patients or their relatives. CBC, LFT, RBS, RFT, H. pylori serology and fecal Ag test were done to all patients. One experienced endoscopist performed an upper GI endoscopy using (PENTAX-EPK-5000 Unit) to all studied patients. Location, size and endoscopic appearance of the lesion were described and six biopsy specimens were minimally taken for histopathologic examination. In all cases 10% formalin was used as fixative. Histopathological examination which carried out by two independent expert pathologists. Histological classification of gastric cancer was based on Lauren’s criteria [<xref ref-type="bibr" rid="scirp.89411-ref8">8</xref>]. Statistical analyses were performed by using SPSS version 20 sciences. Results were presented as mean +/− standard deviation (SD). Nominal data were expressed by percentages. P-values &lt; 0.05 were considered to be statistically significant.</p></sec><sec id="s3"><title>3. Results</title><p>We collected 130 patients with confirmed gastric cancer during the study period. Their demographic data and risk factors were shown in <xref ref-type="table" rid="table1">Table 1</xref>. The most frequent clinical manifestations were shown in <xref ref-type="table" rid="table2">Table 2</xref>. The anatomical site of the tumor within the stomach, the macroscopic and microscopic types were all shown in <xref ref-type="table" rid="table3">Table 3</xref>. The correlation of gastric adenocarcinoma histopathologic types with age, sex, H. pylori infection and location were shown in (<xref ref-type="table" rid="table4">Table 4</xref>, <xref ref-type="table" rid="table5">Table 5</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Gastric cancer is a major health issue worldwide [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>]. Adenocarcinomas represent about 90% of all gastric cancers [<xref ref-type="bibr" rid="scirp.89411-ref18">18</xref>]. It is subdivided into two main</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic characteristics and risk factors of our patients (n = 130)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Characters</th><th align="center" valign="middle"  colspan="3"  >Male</th><th align="center" valign="middle"  colspan="2"  >Female</th><th align="center" valign="middle"  colspan="2"  >Total</th><th align="center" valign="middle" >P value</th></tr></thead><tr><td align="center" valign="middle" >n 93</td><td align="center" valign="middle"  colspan="2"  >(%) 71.5</td><td align="center" valign="middle" >n 37</td><td align="center" valign="middle" >(%) 28.5</td><td align="center" valign="middle" >n 130</td><td align="center" valign="middle" >(%) 100</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle"  colspan="3"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.29</td></tr><tr><td align="center" valign="middle" >Less than 40</td><td align="center" valign="middle"  colspan="2"  >4</td><td align="center" valign="middle" >4.3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.2</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle"  colspan="2"  >8</td><td align="center" valign="middle" >8.7</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >9.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle"  colspan="2"  >8</td><td align="center" valign="middle" >8.7</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >9.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >60 - 69</td><td align="center" valign="middle"  colspan="2"  >21</td><td align="center" valign="middle" >22.8</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >32.4</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >25.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;70</td><td align="center" valign="middle"  colspan="2"  >51</td><td align="center" valign="middle" >55.4</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >35.1</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >49.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Residence</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.21</td></tr><tr><td align="center" valign="middle" >Rural</td><td align="center" valign="middle"  colspan="2"  >83</td><td align="center" valign="middle" >89.2</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >81.1</td><td align="center" valign="middle" >113</td><td align="center" valign="middle" >86.9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle"  colspan="2"  >10</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >18.9</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >13.1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Risk factors</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >H. pylori</td><td align="center" valign="middle"  colspan="2"  >60</td><td align="center" valign="middle" >64.5</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >62.2</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >63.8</td><td align="center" valign="middle" >0.80</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle"  colspan="2"  >52</td><td align="center" valign="middle" >55.9</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >43.1</td><td align="center" valign="middle" >0.00</td></tr><tr><td align="center" valign="middle" >Khat chewing</td><td align="center" valign="middle"  colspan="2"  >73</td><td align="center" valign="middle" >78.5</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >59.5</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >73.1</td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle" >History of gastric cancer in 1<sup>st</sup> or 2<sup>nd </sup>degree relatives</td><td align="center" valign="middle"  colspan="2"  >3</td><td align="center" valign="middle" >3.2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.7</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.1</td><td align="center" valign="middle" >0.87</td></tr><tr><td align="center" valign="middle" >Previous gastric surgery</td><td align="center" valign="middle"  colspan="2"  >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.52</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical presentations of the studied patients (n = 130)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Clinical manifestations</th><th align="center" valign="middle"  colspan="2"  >Male</th><th align="center" valign="middle"  colspan="2"  >Female</th><th align="center" valign="middle"  colspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td></tr><tr><td align="center" valign="middle" >Epigastric pain</td><td align="center" valign="middle" >74</td><td align="center" valign="middle" >79.6</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >86.5</td><td align="center" valign="middle" >106</td><td align="center" valign="middle" >81.5</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >78.5</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >64.9</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >74.6</td></tr><tr><td align="center" valign="middle" >dyspepsia</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >63.4</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >70.3</td><td align="center" valign="middle" >85</td><td align="center" valign="middle" >65.4</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >47.3</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >54.1</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >49.2</td></tr><tr><td align="center" valign="middle" >Dysphagia</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >46.2</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >48.6</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >46.9</td></tr><tr><td align="center" valign="middle" >Postprandial fullness</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >20.4</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >35.1</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >24.6</td></tr><tr><td align="center" valign="middle" >Upper GIT bleeding</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >20.4</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >18.9</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >20</td></tr><tr><td align="center" valign="middle" >Palpable epigastric mass</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >23.7</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.1</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >19.2</td></tr></tbody></table></table-wrap><p>histologic types; intestinal and diffuse type [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref18">18</xref>]. The incidence of intestinal-type adenocarcinoma has declined significantly, but it is still the most common type (70% - 80%) [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>]. There are little studies in Yemen that classify and study adenocarcinoma by subtypes. In our study 130 cases of confirmed gastric cancer were identiﬁed between July 2016 to July 2018 which may denote an increasing incidence of gastric cancer in our country as compared to the reported data from neighboring countries [<xref ref-type="bibr" rid="scirp.89411-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref28">28</xref>]. The mean age of our studied patients was of 64.98 &#177; 15.15 years with a range between 25 - 100 years. The mean age for males was of 67.31 &#177; 14.39 and was of 58.84 &#177; 15.65 for females. Over 70% of</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Anatomical site, macroscopic appearance and histopathological types (n = 130)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  >Response</th><th align="center" valign="middle"  colspan="2"  >Male</th><th align="center" valign="middle"  colspan="2"  >Female</th><th align="center" valign="middle"  colspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td></tr><tr><td align="center" valign="middle"  rowspan="6"  >Anatomical site</td><td align="center" valign="middle"  rowspan="5"  >Non-proximal</td><td align="center" valign="middle" >Body</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >22.8</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >16.7</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >21.2</td></tr><tr><td align="center" valign="middle" >Antrum</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >22.2</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >17.2</td></tr><tr><td align="center" valign="middle" >PM</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >7.6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >11.1</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >8.6</td></tr><tr><td align="center" valign="middle" >MD</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.2</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.8</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.3</td></tr><tr><td align="center" valign="middle" >Diffuse</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >3.3</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8.3</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4.7</td></tr><tr><td align="center" valign="middle" >Proximal</td><td align="center" valign="middle" >Cardia &amp; Fundus</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >48.9</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >38.9</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >46.1</td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="3"  >Macroscopic appearance</td><td align="center" valign="middle" >Ulcerative, infiltrative</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >64.9</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >72.1</td></tr><tr><td align="center" valign="middle" >Polypoidal</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >14.1</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >21.6</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >16.3</td></tr><tr><td align="center" valign="middle" >Diffuse</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >10.9</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >13.5</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >11.6</td></tr><tr><td align="center" valign="middle"  colspan="2"   rowspan="7"  >Histopathologic type</td><td align="center" valign="middle" >Adenocarcinoma</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Intestinal type</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >78.5</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >70.2</td><td align="center" valign="middle" >99</td><td align="center" valign="middle" >76.2</td></tr><tr><td align="center" valign="middle" >Diffuse type</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >15.1</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >18.9</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >16.2</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Squamous</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.7</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >GIST</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.7</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.5</td></tr><tr><td align="center" valign="middle" >Lymphomas</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.3</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5.4</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >4.6</td></tr></tbody></table></table-wrap><p>PM = Proximal and middle part of the stomach. MD = middle and distal part of the stomach.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Histopathological classification of gastric adenocarcinoma in correlation with sex (no = 120)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"   rowspan="2"  >Histopathological type</th><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Male</th><th align="center" valign="middle"  colspan="2"  >Female</th><th align="center" valign="middle"  colspan="2"  >Total</th></tr></thead><tr><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td><td align="center" valign="middle" >n</td><td align="center" valign="middle" >(%)</td></tr><tr><td align="center" valign="middle"  rowspan="5"  >Intestinal type</td><td align="center" valign="middle"  colspan="2"  >Well differentiated</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >31.0</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >33.3</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >31.7</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Moderate differentiated</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >11.5</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >12.1</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >11.7</td></tr><tr><td align="center" valign="middle"  colspan="2"  >poorly differentiated</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >32.2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >24.2</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >30</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Mucinous</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.7</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Papillary</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.5</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Diffuse type</td><td align="center" valign="middle"  colspan="2"  >Undifferentiated</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >6.9</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6.1</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.7</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Signet cell ca</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >9.2</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >15.2</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >10.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle"  colspan="2"  ></td><td align="center" valign="middle" >87</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>male patients and over 60% of female patients were over 60 years of age and this is in consistent with those reported for patients from high risk countries and medical literatures [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref28">28</xref>]. Male to female ratio in our study was 2.5:1 which is similar to what is known in the medical literatures and previous studies from our country and neighboring counties [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref32">32</xref>]. The risk factors studied in our research were H. pylori infection, khat</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Correlation of gastric adenocarcinoma (n = 120) with age, sex, H pylori infection &amp; tumor location</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Histological types</th><th align="center" valign="middle" >Age (years)</th><th align="center" valign="middle"  colspan="4"  >Sex</th><th align="center" valign="middle"  colspan="2"   rowspan="2"  >H pylori nfection</th><th align="center" valign="middle"  colspan="4"  >Location</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Mean</td><td align="center" valign="middle"  colspan="2"  >Male</td><td align="center" valign="middle"  colspan="2"  >Female</td><td align="center" valign="middle"  colspan="2"  >Proximal</td><td align="center" valign="middle"  colspan="2"  >Distal</td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >no</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >Intestinal</td><td align="center" valign="middle" >65.12 &#177; 15.1</td><td align="center" valign="middle" >73</td><td align="center" valign="middle" >84.9</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >81.3</td><td align="center" valign="middle" >65</td><td align="center" valign="middle" >65.7</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50.5</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >49.5</td></tr><tr><td align="center" valign="middle" >Diffuse</td><td align="center" valign="middle" >67.6 &#177; 13.2</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >15.1</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >18.8</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >68.4</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >42.1</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >57.9</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >65.5 &#177; 14.8</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >66.1</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >49.2</td><td align="center" valign="middle" >60</td><td align="center" valign="middle" >50.8</td></tr><tr><td align="center" valign="middle" >P value</td><td align="center" valign="middle" >0.83</td><td align="center" valign="middle"  colspan="4"  >0.51</td><td align="center" valign="middle"  colspan="2"  >0.92</td><td align="center" valign="middle" ></td><td align="center" valign="middle"  colspan="2"  >0.81</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>chewing, smoking and others (<xref ref-type="table" rid="table1">Table 1</xref>). H. pylori infection prevalence in developing countries including Yemen ranges between 70% and 90% in adult population [<xref ref-type="bibr" rid="scirp.89411-ref33">33</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref34">34</xref>], compared to a much lower prevalence in developed countries such as USA where the prevalence is &lt;20% at the age of 20 years and 50% at 50 years [<xref ref-type="bibr" rid="scirp.89411-ref35">35</xref>]. It has been reported in Yemen that the prevalence of H. pylori infection among patients underwent upper GIT endoscopy in Sana’a major hospitals was very high (99.6%) [<xref ref-type="bibr" rid="scirp.89411-ref36">36</xref>] ; however prevalence data for the general population are lacking. In our studied patients the H. pylori seropositivity was seen in 63.8%. This high prevalence of H. pylori infection in addition to other risk factors could explain the increasing incidence of gastric cancer in our country. Smoking is a risk factor for many cancers [<xref ref-type="bibr" rid="scirp.89411-ref37">37</xref>]. A significant relationship between smoking and gastric cancer was reported in many studies [<xref ref-type="bibr" rid="scirp.89411-ref38">38</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref40">40</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref41">41</xref>]. In a large population-based study in Europe (EPIC), 17.6% of gastric cancer cases were attributed to smoking [<xref ref-type="bibr" rid="scirp.89411-ref39">39</xref>]. In our study smoking was encountered in 43.1% more in males (55.9%) than in females (10.8%). Khat chewing habit became very common in Yemen where approximately 60% - 90% of males and 35% of females chew Khat daily [<xref ref-type="bibr" rid="scirp.89411-ref42">42</xref>]. Chemically khat leaves contains cathinone (S-(-)-a-aminopropiophenone) and cathine (S, S-(-)-norpseudoephedrine [<xref ref-type="bibr" rid="scirp.89411-ref41">41</xref>]. Farmers used many kinds of pesticides mostly in illegal way for most of the cultivated plants including Khat. Khat chewing was reported in many studies to be a risk factor in many disorders including cancers [<xref ref-type="bibr" rid="scirp.89411-ref43">43</xref>]. In our study 73.1% (78.5% of males and 59.5% of females) were chewed Khat. There is statistically significant differences regarding smoking and Khat chewing with sex (P value = 0.00 and 0.03 respectively) in which smoking and Khat chewing were more in males (<xref ref-type="table" rid="table1">Table 1</xref>). The proximal gastric cancer was found to be the most common in our community in both males and females, accounting for 48.9% of male patients and 39.9% of female patients, this is similar to the reported studies from western countries and our previous study and medical literatures [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref45">45</xref>], but not in agreement with many studies from developing countries [<xref ref-type="bibr" rid="scirp.89411-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref46">46</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref47">47</xref>]. In developed countries, increasing cardia gastric cancer was believed to be due to reduction in the incidence of H. pylori infection and subsequently reduction in the distally located gastric cancer at the expense of the proximal one [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>]. In our country H. pylori infection incidence still high and despite of this, the proximal location in our studied patients was the commonest (<xref ref-type="table" rid="table3">Table 3</xref>). This may reflect emerging of new risk factors in our community such as chewing khat habit and/or the pesticides used in it and in mostly all kinds of vegetables and fruits cultured in our country, as it is already reported in some studies [<xref ref-type="bibr" rid="scirp.89411-ref48">48</xref>]. The most frequent symptoms reported by stomach cancer patients in the present study were abdominal pain (81.5%), weight loss (74.6%), dyspepsia (65.4%), vomiting (49.2%) and dysphagia (46.9%) <xref ref-type="table" rid="table2">Table 2</xref>. The proportions of presenting symptoms in the present study are much higher than those reported by Selcukbiricik et al. [<xref ref-type="bibr" rid="scirp.89411-ref49">49</xref>]. Because of active screening programs in Eastern Asia, and developed world many patients are now detected while asymptomatic [<xref ref-type="bibr" rid="scirp.89411-ref50">50</xref>]. However, most patients with gastric cancer in our country are presented in advanced stages as indicated by the high percentage (46.9%) of patients presented with dysphagia in this study and other studies from Yemen [<xref ref-type="bibr" rid="scirp.89411-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref44">44</xref>]. This could be attributed to the poverty and a little accessibility to the available specialized health care centers in one hand, and lack of active screening programs and policies in the country on the other hand.</p><p>Analyzing the histologic subtypes of gastric cancer in our patients, gastric adenocarcinoma was found in 120 (92.3%); where the intestinal type seen in 99 cases (82.5%) and diffuse type seen in 21 cases (17.5%) and the other types of gastric cancer were lymphoma in 4.6%, GIST in 1.5% and squamous type in 1.5% (<xref ref-type="table" rid="table3">Table 3</xref>) and this is similar to some degree with studies from our country and neighboring area [<xref ref-type="bibr" rid="scirp.89411-ref32">32</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref51">51</xref>], and in discordance with M.G. Mart&#237;nez-Galindo et al in which diffuse-type adenocarcinoma was reported in 55.2%, intestinal-type in 28.2% [<xref ref-type="bibr" rid="scirp.89411-ref52">52</xref>]. This difference between our study results and the results of M.G. Mart&#237;nez-Galindo et al could be explained by using different classification system. In our study tubular adenocarcinoma was the predominant type seen in 88 (73.4%) patients in which well differentiated grade seen in 38 (31.7%), moderately differentiated in 14 (11.7%) and poorly differentiated in 36 (30%). This was followed by signet ring cell, mucinous, undifferentiated and papillary adenocarcinoma in 13 (10.8%), 8 (6.7%), 8 (6.7%) and 3 (2.5%) respectively. This is consistent with other studies in Yemen [<xref ref-type="bibr" rid="scirp.89411-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref51">51</xref>]. We compared between intestinal and diffuse type adenocarcinoma regarding the mean age, sex, H. pylori infection and location of the tumor and we found no significant statistical differences between intestinal and diffuse type regarding all studied variables as P value was &gt;0.05 (<xref ref-type="table" rid="table5">Table 5</xref>), and this is in agreement with a study from KSA done by Hamdi et al. regarding the mean age and sex [<xref ref-type="bibr" rid="scirp.89411-ref53">53</xref>], but not in agreement with what is known in the global literatures and other studies [<xref ref-type="bibr" rid="scirp.89411-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.89411-ref53">53</xref>]. This difference should be further investigated considering various geographical and demographical features of our country.</p></sec><sec id="s5"><title>5. Conclusions</title><p>Clinical and pathological characteristics of gastric adenocarcinoma among Yemeni patients are somewhat similar to those in other parts of the world.</p><p>Histopathologically, intestinal-type adenocarcinoma with their different sub-types was the most common types of stomach cancers among Yemeni patients.</p><p>Proximally located gastric cancer is more frequent in our patients in both sexes.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Kassim, A., Thabet, S., Al-Fakih, S., Alqobaty, M., Alathwary, R. and Ameen, S. (2018) Clinical and Histopathological Characteristics of Gastric Adenocarcinoma in Yemeni Patients: A 2 Years Prospective Study. Open Access Library Journal, 5: e5075. https://doi.org/10.4236/oalib.1105075</p></sec></body><back><ref-list><title>References</title><ref id="scirp.89411-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Katherine, D.C. and Alfred, I.N. (2006) Epidemiology of Gastric Cancer. World Journal of Gastroenterology, 12, 354-362. https://doi.org/10.3748/wjg.v12.i3.354</mixed-citation></ref><ref id="scirp.89411-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Parkin, D.M., Pisani, P. and Ferlay, J. (1993) Estimates of the Worldwide Incidence of Eighteen Major Cancers in 1985. International Journal of Cancer, 54, 594-606. https://doi.org/10.1002/ijc.2910540413</mixed-citation></ref><ref id="scirp.89411-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Parveen, K. and Kumar, M.C. (2012) Clark’s Clinical Medicine. 8th Edition, Vol. 1, Elsevier, UK, 251-253.</mixed-citation></ref><ref id="scirp.89411-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Felix, B., Elfriede, B., Uta, D., Arnulf, H.H. and Stefan, M. (2014) Pathohistological Classification Systems in Gastric Cancer: Diagnostic Relevance and Prognostic Value. World Journal of Gastroenterology, 20, 5679-5684. https://doi.org/10.3748/wjg.v20.i19.5679</mixed-citation></ref><ref id="scirp.89411-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Globocan (2012) Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. World Health Organization.</mixed-citation></ref><ref id="scirp.89411-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Junli, M., Hong, S., Linda, K. and Shan, Z. (2016) Lauren Classification and Individualized Chemotherapy in Gastric Cancer (Review). Oncology Letters, 11, 2959-2964. https://doi.org/10.3892/ol.2016.4337</mixed-citation></ref><ref id="scirp.89411-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Maxine, A.P., Stephen, J.M. and Michael, W.R. (2019) Current Medical Diagnosis &amp; Treatment. 58th Edition, Vol. 1, McGraw-Hill Education, New York, 1641-1644.</mixed-citation></ref><ref id="scirp.89411-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Lauren, T. (1965) The Two Histological Main Types of Gastric Carcinoma. Acta Pathologica Microbiologica Scandinavica, 64, 34. https://doi.org/10.1111/apm.1965.64.1.31</mixed-citation></ref><ref id="scirp.89411-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Pelayo, C. and Blanca, P. (2011) Helicobacter pylori Infection and Gastric Ad-enocarcinoma. US Gastroenterol Hepatol Rev., 7, 59-64.</mixed-citation></ref><ref id="scirp.89411-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Lauren, P. (1965) The Two Histological Main Types of Gastric Car-cinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathologica Microbi-ologica Scandinavica, 64, 31-49. https://doi.org/10.1111/apm.1965.64.1.31</mixed-citation></ref><ref id="scirp.89411-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mu?oz, N., Correa, P., Cuello, C. and Duque, E. (1968) Histologic Types of Gastric Carcinoma in High- and Low-Risk Areas. International Journal of Cancer, 3, 809-818. https://doi.org/10.1002/ijc.2910030614 </mixed-citation></ref><ref id="scirp.89411-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Kaneko, S. and Yoshimura, T. (2001) Time Trend Analysis of Gastric Cancer Incidence in Japan by Histological Types, 1975-1989. British Journal of Cancer, 84, 400-405. https://doi.org/10.1054/bjoc.2000.1602</mixed-citation></ref><ref id="scirp.89411-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Henson, D.E., Dittus, C., Younes, M., Nguyen, H. and Albores-Saavedra, J. (2004) Differential Trends in the Intestinal and Diffuse Types of Gastric Carcinoma in the United States, 1973-2000: Increase in the Signet Ring Cell Type. Archives of Pathology &amp; Laboratory Medicine, 128, 765-770.</mixed-citation></ref><ref id="scirp.89411-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Blot, W.J., Devesa, S.S., Kneller, R.W. and Fraumeni, J.F. (1991) Rising Incidence of Adenocarcinoma of the Esophagus and Gastric Cardia. JAMA, 265, 1287-1289. https://doi.org/10.1001/jama.1991.03460100089030</mixed-citation></ref><ref id="scirp.89411-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Brown, L.M. and Devesa, S.S. (2002) Epidemiologic Trends in Esophageal and Gastric Cancer in the United States. Surgical Oncology Clinics, 11, 235-256.</mixed-citation></ref><ref id="scirp.89411-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Shen, H., Xu, Y., Qian, Y., Yu, R., Qin, Y., Zhou, L., Wang, X., Spitz, M.R. and Wei, Q. (2000) Polymorphisms of the DNA Repair Gene XRCC1 and Risk of Gastric Cancer in a Chinese Population. International Journal of Cancer, 88, 601-606. https://doi.org/10.1002/1097-0215(20001115)88:4&lt;601::AID-IJC13&gt;3.0.CO;2-C</mixed-citation></ref><ref id="scirp.89411-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Dan, L.L., Dennis, L.K., Larry, J., Anthony, S.F., Stephen, L.H. and Joseph, L. (2012) Harrison’s Principle of Internal Medicine. 18th Edition, Vol. 2, John Kretschmer, New York, 765-767.</mixed-citation></ref><ref id="scirp.89411-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Christine, A.L.D., Elizabeth, M. and John, R.G. (2012) Gastrointestinal and Liver Pathology. 2nd Edition, Vol. 1, John R. Goldblum, Philadelphia, 150-157.</mixed-citation></ref><ref id="scirp.89411-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Lee, Y.Y. and Derakhshan, M.H. (2013) Environmental and Lifestyle Risk Factors of Gastric Cancer. Archives of Iranian Medicine, 16, 358-365.</mixed-citation></ref><ref id="scirp.89411-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Reza, M., Mohammad, H.D. and Zinab, M. (2009) Gastric Cancer in Iran: Epidemiology and Risk Factors. Archives of Iranian Medicine, 12, 576-583.</mixed-citation></ref><ref id="scirp.89411-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Simán, J.H., Forsgren, A., Berglund, G., et al. (1997) Association between Helicobacter pylori Infection and Gastric Carcinoma in the City of Malmo, Sweden. A Prospective Study. Scandinavian Journal of Gastroenterology, 32, 1215-1221. https://doi.org/10.3109/00365529709028150</mixed-citation></ref><ref id="scirp.89411-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Bani-Hani, K., Yaghan, R., Heis, H., Shatnawi, N., Katalka, I., Bani-Hani, A., et al. (2004) Gastric Malignancies in Northen Jordan with Special Emphasis on Descriptive Epidemiology. World Journal of Gastroenterology, 10, 2174-2178. https://doi.org/10.3748/wjg.v10.i15.2174</mixed-citation></ref><ref id="scirp.89411-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Raha, A., Osman, H., Al-Enizi, H. and Tashkandi, A. (2016) Incidence of Gastric Carcinoma at King Faisal Specialist Hospital-Jeddah Saudi Arabia: A Hospital-Based Study. Integrative Molecular Medicine, 3, 606-611. https://doi.org/10.15761/IMM.1000211</mixed-citation></ref><ref id="scirp.89411-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">El Hassan, A., El Hassan, L., Mudawi, H., Gasim, B., Own, A., Elamin, E., Ibn Ouf, M., et al. (2008) Malignant Gastric Tumors in Sudan: A Report from a Single Pathology Center. Hematology/Oncology and Stem Cell Therapy, 1, 130-132. https://doi.org/10.1016/S1658-3876(08)50044-6</mixed-citation></ref><ref id="scirp.89411-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">International Agency for Research on Cancer (2012) Globocan, Cancer Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer, Lyon.</mixed-citation></ref><ref id="scirp.89411-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Heyam, A.A., Manar, H.H., Mohand, W.A., Mohammad, A.A. and Ali, A.A. (2017) Epidemiologic Characteristics of Gastric Malignancies among Jordan University Hospital Patients. Saudi Medical Journal, 38, 965-967. https://doi.org/10.15537/smj.2017.9.19371</mixed-citation></ref><ref id="scirp.89411-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Haitham Al-Mahrouqi, L.P. and Sharples, K. (2011) Incidence of Stomach Cancer in Oman and the Other Gulf Cooperation Council Countries. Oman Medical Journal, 26, 58-62.</mixed-citation></ref><ref id="scirp.89411-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">David, A.S., Abdul-Basit, A., Mohammad, I., Abdul-Rauf, K. and Abdul-Naser, A.B. (1995) Gastric Cancer: A Clinicopathological Analysis of 54 Cases Seen at Asir Central Hospital. Saudi Medical Journal, 16, 308-311.</mixed-citation></ref><ref id="scirp.89411-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Stomach Cancer. National Cancer Institute.</mixed-citation></ref><ref id="scirp.89411-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., et al. (2010) Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917. https://doi.org/10.1002/ijc.25516</mixed-citation></ref><ref id="scirp.89411-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Office for National Statistics (2015) Cancer Statistics Registration, England: 2013. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/2015-07-10</mixed-citation></ref><ref id="scirp.89411-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Abdulla, S.A. and Saleh, M.A. (2013) Histopathology of Gastric Cancer in Yemen Seven Years Retrospective Analysis. Sudan JMS, 8, 91-92.</mixed-citation></ref><ref id="scirp.89411-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Al-Moagel, M.A., Evans, D.G., Abdulghani, M.E., Adam, E., Evans, D.J., Malaty, H.M., et al. (1990) Prevalence of Helicobacter pylori (Formerly Campylobacter) Infection in Saudi Arabia, and Comparison of Those with and without Upper Gastrointestinal Symptoms. The American Journal of Gastroenterology, 85, 944-948.</mixed-citation></ref><ref id="scirp.89411-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Al-Makdad, A.M., Al-Dholaee, M.H., Thabet, A.A.K., Al-Haimi, M.A., Balfaqih, O.S. and Al-Hadad, A.M. (2013) Prevalence of Helicobacter pylori Infection in Yemeni Patients. Yemeni Journal for Medical Sciences, 7, 37.</mixed-citation></ref><ref id="scirp.89411-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Graham, D.Y., Malaty, H.M., Evans, D.G., Evans, D.J., Klein, P.D. and Adam, E. (1991) Epidemiology of Helicobacter pylori in an Asymptomatic Population in the United States. Effect of Age, Race, and Socioeconomic Status. Gastroenterology, 100, 1495-1501. https://doi.org/10.1016/0016-5085(91)90644-Z</mixed-citation></ref><ref id="scirp.89411-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Al-Shami, H.Z. (2002) Prevalence of Helicobacter pylori Infection among Patients Underwent Upper Gastrointestinal Tract Endoscopy in Sana’a Major Hospitals. Thesis in MSc, Faculty of Medicine, Sana’a University, Yemen.</mixed-citation></ref><ref id="scirp.89411-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Doll, R., Peto, R., Boreham, J. and Sutherland, I. (2005) Mortality from Cancer in Relation to Smoking: 50 Years Observations on British Doctors. British Journal of Cancer, 92, 426-429. https://doi.org/10.1038/sj.bjc.6602359</mixed-citation></ref><ref id="scirp.89411-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Sj?dahl, K., Lu, Y., Nilsen, T.I., Ye, W., Hveem, K., Vatten, L., et al. (2007) Smoking and Alcohol Drinking in Relation to Risk of Gastric Cancer: A Population-Based, Prospective Cohort Study. International Journal of Cancer, 120, 128-132. https://doi.org/10.1002/ijc.22157 </mixed-citation></ref><ref id="scirp.89411-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">González, C.A., Pera, G., Agudo, A., Palli, D., Krogh, V., Vineis, P., et al. (2003) Smoking and the Risk of Gastric Cancer in the European Prospective Investigation into Cancer and Nutri-tion (EPIC). International Journal of Cancer, 107, 629-634. https://doi.org/10.1002/ijc.11426</mixed-citation></ref><ref id="scirp.89411-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Ghadimi, R., Taheri, H., Suzuki, S., Kashifard, M., Hosono, A., Esfandiary, I., et al. (2007) Host and Environmental Factors for Gastric Cancer in Babol, the Caspian Sea Coast, Iran. European Journal of Cancer Prevention, 16, 192-195. https://doi.org/10.1097/01.cej.0000220639.61717.67</mixed-citation></ref><ref id="scirp.89411-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Koizumi, Y., Tsubono, Y., Nakaya, N., Kuriyama, S., Shibuya, D., Matsuoka, H., et al. (2004) Cigarette Smoking and the Risk of Gastric Cancer: A Pooled Analysis of Two Prospective Studies in Japan. International Journal of Cancer, 112, 1049-1055. https://doi.org/10.1002/ijc.20518</mixed-citation></ref><ref id="scirp.89411-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Balint, E.E., Falkay, G. and Balint, G.A. (2009) Khat: A Controversial Plant. Wiener Klinische Wochenschrift, 121, 604-614. https://doi.org/10.1007/s00508-009-1259-7</mixed-citation></ref><ref id="scirp.89411-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Hassan, N.A.G.M., Gunaid, A.A. and Murray-Lyon, I.M. (2007) Khat (Catha edulis): Health Aspects of Khat Showing. La Revue de santé de la Méditerranée Orientale, 13, 706-717.</mixed-citation></ref><ref id="scirp.89411-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Abdulgafoor, K., Mo-hammed, A., Fayed, A., Ramea, A. and Sana, A. (2018) Clinicopathological Pattern of Gastric Cancer of Yemeni Patients in Ibb Governorate. Open Access Library Journal, 5, 1-10. https://doi.org/10.4236/oalib.1104415</mixed-citation></ref><ref id="scirp.89411-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Selcukbiricik, F., Buyukunal, E., Tural, D., Ozguroglu, M., Demirelli, F. and Serdengecti, S. (2013) Clinicopathological Features and Outcomes of Patients with Gastric Cancer: A Single-Center Experience. World Journal of Gastroenterology, 19, 2154-2161. https://doi.org/10.3748/wjg.v19.i14.2154</mixed-citation></ref><ref id="scirp.89411-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Nassima, C., Khan, A.R., Romana, M. and Saud, L. (2007) Histopathology of Gastric Cancer in Kashmir—A Five Year Retrospective Analysis. JK Science, 9, 21-24.</mixed-citation></ref><ref id="scirp.89411-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Miomir, P., Aleksandar, K., Nebojsa, D., Vuka, K., Zoran, R., Milan, R., Nikola, I. and Ivan, P. (2004) The Importance of Primary Gastric Cancer Location in 5-Year Survival Rate. Arch Oncology, 12, 51.</mixed-citation></ref><ref id="scirp.89411-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Ejaz, S., Akram, W., Lim, C.W., et al. (2004) Endocrine Disrupting Pesticides: A Leading Cause of Cancer among Rural People in Pakistan. Experimental Oncology, 26, 98-105.</mixed-citation></ref><ref id="scirp.89411-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Acraanen, M.E., Dekker, W., Ferw erda, J., Bolk, P. and Tytqat, G.N. (1991) Early Gastric Cancer: A Clinicopathologic Study. Journal of Clinical Gastroenterology, 13, 274-283. https://doi.org/10.1097/00004836-199106000-00006</mixed-citation></ref><ref id="scirp.89411-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Waleed, M.A.G., Mohammed, A.A. and Taha, B. (2017) Clinicopathologic Characteristics of Stomach Cancer among Patients Admitted to the Surgical Departments of Teaching Hospitals in Sana’a, Yemen. Yemeni Journal for Medical Sciences, 11, 38-45.</mixed-citation></ref><ref id="scirp.89411-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Martínez-Galindo, M.G., Zamarripa-Dorsey, F., Carmo-na-Castaneda, A., Angeles-Labra, A., Penavera-Hernández, R., Ugarte-Briones, C. and Blanco-Vela, C.I. (2015) Histopathologic Characteristics of Gastricadenocarcinoma in Mexican Patients: A 10-Year Experience at the Hospital Juárez de México. Revista de Gastroenterología de México, 80, 21-26. https://doi.org/10.1016/j.rgmx.2014.11.002</mixed-citation></ref><ref id="scirp.89411-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Hamdi, J. and Morad, N.A. (1994) Gastric Cancer in Southern Saudi Arabia. Annals of Saudi Medicine, 14, 195-197.</mixed-citation></ref><ref id="scirp.89411-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Ashis, K.S., Somnath, M. and Subhas, C.H. (2013) Epidemiology of Gastric Cancer in the Gangetic Areas of West Bengal. Gastroenterology, 2013, Article ID: 823483. https://doi.org/10.1155/2013/823483</mixed-citation></ref></ref-list></back></article>